Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. 2004

Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
International Research Center for Medical Education, The University of Tokyo, Tokyo, Japan. shunsaku-tky@umin.ac.jp

BACKGROUND A double-blind randomized controlled trial was carried out to assess the effect of sour milk, containing two tripeptides (valine-proline-proline and isoleucine-proline-proline), on blood pressure (BP). METHODS A total of 46 borderline hypertensive men aged 23 to 59 years were recruited at their workplace for this trial. Subjects were randomly allocated into two groups; sour milk drink group (S-group, n = 23) and placebo (acidified milk) drink group (P-group, n = 23) for 4 weeks. Blood pressure was measured twice at each occasion by a physician, at the health center of the company, with a mercury at baseline, 2 and 4 weeks. Statistical analysis was performed by SPSS 10.0J. RESULTS The S-group and P-group showed no significant difference in baseline systolic BP (mean [SD], S: 147.6 [9.6], P: 145.3 [13.0]) or diastolic BP (S: 95.3 [9.9], P: 91.5 [9.6]). In the S-group, change in systolic BP at 2 and 4 weeks were -4.3 mm Hg (95% confidence interval [CI] -8.3 to -0.4; P = .032) and -5.2 mm Hg (95% CI -10.1 to -0.3; P = .039), both statistically significant. Diastolic BP showed change from -1.7 mm Hg (95% CI -5.4 to 2.0) at 2 weeks and -2.0 (95% CI -5.4 to 1.5) at 4 weeks, respectively. In the P-group, change in systolic BP were -0.5 (95% CI -5.8 to 4.8) at 2 weeks and -3.7 (95% CI -8.3 to 0.9) and change in diastolic BP were -0.6 (95% CI -4.7 to 3.6) and -0.3 (95% CI -3.9 to 3.3), which were not statistically significant. CONCLUSIONS This trial demonstrated the beneficial effect of sour milk on BP in borderline hypertensive men who were not taking antihypertensive medication.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008892 Milk The off-white liquid secreted by the mammary glands of humans and other mammals. It contains proteins, sugar, lipids, vitamins, and minerals. Cow Milk,Cow's Milk,Milk, Cow,Milk, Cow's
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D019587 Dietary Supplements Products in capsule, tablet or liquid form that provide dietary ingredients, and that are intended to be taken by mouth to increase the intake of nutrients. Dietary supplements can include macronutrients, such as proteins, carbohydrates, and fats; and/or MICRONUTRIENTS, such as VITAMINS; MINERALS; and PHYTOCHEMICALS. Food Supplements,Neutraceuticals,Dietary Supplementations,Food Supplementations,Herbal Supplements,Nutraceuticals,Nutriceuticals,Dietary Supplement,Food Supplement,Herbal Supplement,Neutraceutical,Nutraceutical,Nutriceutical,Supplement, Food,Supplement, Herbal,Supplementations, Dietary,Supplements, Dietary,Supplements, Food,Supplements, Herbal

Related Publications

Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
November 1996, The American journal of clinical nutrition,
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
November 2015, Journal of integrative medicine,
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
January 1996, Health psychology : official journal of the Division of Health Psychology, American Psychological Association,
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
August 1993, The American journal of cardiology,
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
June 2013, Complementary therapies in medicine,
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
March 1999, Hypertension (Dallas, Tex. : 1979),
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
June 1985, Clinical science (London, England : 1979),
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
March 1996, American journal of hypertension,
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
August 2021, British journal of clinical pharmacology,
Shunsaku Mizushima, and Kenji Ohshige, and Junko Watanabe, and Maki Kimura, and Takashi Kadowaki, and Yasunori Nakamura, and Osamu Tochikubo, and Hirotsugu Ueshima
May 2024, Journal of clinical biochemistry and nutrition,
Copied contents to your clipboard!